Category Archives: COVID19

SARS-CoV-2 lateral flow antigen tests: evaluation of VUI-202012/01

Published 23 December 2020 Detection of an epidemiological cluster associated with a new variant of concern 1. Working with academic collaborators at the University of Oxford, PHE Porton Down has been evaluating the performance of lateral flow devices (LFDs) since mid-August 2020. Over 60 have been considered to date, approximately 30% of which have progressed to extended evaluation […]

Investigation of novel SARS-COV-2 variant-Variant of Concern 202012/01

Variant of Concern 202012/01 Detection of an epidemiological cluster associated with a new variant of concern Analysis of routinely available genomic data in Kent, England was undertaken as part of an epidemiological investigation to investigate increasing incidence on 8 December 2020. Although only 4% (255/6130) of Kent cases had available genomes through COG-UK sequencing, a […]

CRISPR-based tools for Coronavirus Disease 2019 (COVID-19) test

Full-text Download View Knowledge Base – Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro — A comparison of PCR vs Immunoassay vs Crispr-Based test>> Author:Huajun Bai1 Xiaolong Cai1, 2*  Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by […]

Immunoassay in Coronavirus Disease 2019 (COVID-19) test

Full-text Download View Knowledge Base – Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro — A comparison of PCR vs Immunoassay vs Crispr-Based test>> Author:Huajun Bai1 Xiaolong Cai1, 2*  Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by […]

RT-PCR (Real time -PCR) in Coronavirus Disease 2019 (COVID-19) test

Full-text Download View Knowledge Base – Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro — A comparison of PCR vs Immunoassay vs Crispr-Based test>> Author:Huajun Bai1 Xiaolong Cai1, 2*  Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by […]

Background of Coronavirus Disease 2019 (COVID-19, 2019-nCoV)

Author:Huajun Bai1 Xiaolong Cai1, 2*  Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by 2019 novel coronavirus (2019-nCoV), has been a global public health threat and caught the worldwide concern. Scientists throughout the world are sparing all efforts to […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 14 3 June 2021 This briefing provides an update on previous briefings up to 27 May 2021 Summary There are 5 variants of concern and 9 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of Delta (VOC21APR-02, B.1.617.2). A separate report is published covering our […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 13 27 May 2021 This briefing provides an update on previous briefings up to 22 May 202 Summary There are 5 variants of concern and 9 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of VOC-21APR02 (B.1.617.2) and information on a new variant under investigation […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 12 22 May 2021 This briefing provides an update on previous briefings up to 13 May 2021 Summary There are 5 variants of concern and 8 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of VOC-21APR02 (B.1.617.2) and information on a new variant under investigation […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 11 13 May 2021 This briefing provides an update on previous briefings up to 7 May 2021 Summary There are 5 variants of concern and 7 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of VOC-21APR02 (B.1.617.2). A separate report is published covering our routine […]